Seeking Alpha

More on St. Jude Medical (STJ) Q3: net profit drops to $176M from $227M, due to charges of $80M...

More on St. Jude Medical (STJ) Q3: net profit drops to $176M from $227M, due to charges of $80M that are mostly related to restructuring. Outlook: Q4 EPS of $0.86-$0.88 vs. consensus of $0.89. FY EPS of $3.42-$3.44 vs. consensus of $3.43 and prior guidance of $3.40-$3.45. Board authorizes $300M repurchase program. Shares -3.6%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)